Medigene AG (MDG1.DE)
EUR 1.08
(-1.64%)
EUR 1.08
(-1.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.11 Million | 11.97 Million | -10.75 Million | -24.78 Million | -16.42 Million | -10.14 Million |
| Net Income | -16.17 Million | -9.37 Million | -10.28 Million | -28.4 Million | -19.91 Million | -17 Million |
| Depreciation & Amortization | 1.46 Million | 21.85 Million | 3.42 Million | 6.47 Million | 2.37 Million | 1.57 Million |
| Deferred income taxes | -962 Thousand | - | -214 Thousand | -1.02 Million | -1.11 Million | -691 Thousand |
| Stock-based compensation | 307 Thousand | 350 Thousand | 651 Thousand | 662 Thousand | 492 Thousand | 961 Thousand |
| Change in working capital | -297 Thousand | -885 Thousand | -4.68 Million | -2.86 Million | 1.45 Million | 5.09 Million |
| Other non-cash items | 547 Thousand | 33 Thousand | 347 Thousand | 365 Thousand | 292 Thousand | -74 Thousand |
| Investing Cash Flow | 2.38 Million | -12 Million | 4.02 Million | 21.11 Million | 24.16 Million | -19.47 Million |
| Investments in PPE | -664 Thousand | -1 Million | -125 Thousand | -484 Thousand | -1.42 Million | -1.01 Million |
| Acquisitions | 48 Thousand | 2000.00 | 33 Thousand | 24 Thousand | - | 21 Million |
| Investment purchases | -3.04 Million | -11 Million | -33 Thousand | -24 Thousand | - | -20 Million |
| Sales/Maturities of investments | 3 Million | -2000.00 | 4.11 Million | 20.57 Million | 24.59 Million | 537 Thousand |
| Other Investing Activities | 3.04 Million | 2000.00 | 33 Thousand | 1.02 Million | 1 Million | -20 Million |
| Financing Cash Flow | -776 Thousand | -282 Thousand | -1.03 Million | -826 Thousand | -469 Thousand | 29.29 Million |
| Debt repayment | -171 Thousand | -171 Thousand | -191 Thousand | -284 Thousand | -203 Thousand | -730 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 21 Thousand | 32.44 Million |
| Other Financing Activities | -605 Thousand | -111 Thousand | -842 Thousand | -542 Thousand | -287 Thousand | -3.14 Million |
| Accounts receivables | 2.56 Million | -2.28 Million | 914 Thousand | 2.65 Million | 341 Thousand | 605 Thousand |
| Accounts payables | -294 Thousand | 137 Thousand | 65 Thousand | -939 Thousand | 15 Thousand | 633 Thousand |
| Inventory | - | - | - | - | 305 Thousand | 426 Thousand |
| Other working capital | -2.56 Million | 1.25 Million | -5.66 Million | -4.57 Million | 797 Thousand | 4.66 Million |
| Cash at beginning of period | 22.22 Million | 22.41 Million | 30.03 Million | 34.68 Million | 27.4 Million | 27.72 Million |
| Cash at end of period | 8.67 Million | 22.22 Million | 22.41 Million | 30.03 Million | 34.68 Million | 27.4 Million |
| Capital Expenditure | -664 Thousand | -1 Million | -125 Thousand | -484 Thousand | -1.42 Million | -1.01 Million |
| Effect of forex changes on cash | -39 Thousand | 118 Thousand | 144 Thousand | -155 Thousand | - | - |
| Net cash flow / Change in cash | -13.55 Million | -193 Thousand | -7.61 Million | -4.64 Million | 7.27 Million | -316 Thousand |
| Free Cash Flow | -15.78 Million | 10.96 Million | -10.87 Million | -25.27 Million | -17.85 Million | -11.15 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.08 Million | -3.36 Million | -16.17 Million | -4.6 Million | -4.6 Million | -4.05 Million |
| Depreciation & Amortization | 351.5 Thousand | 351.5 Thousand | 1.46 Million | 396 Thousand | 396 Thousand | 335.5 Thousand |
| Deferred income taxes | - | - | -962 Thousand | -313.5 Thousand | - | -495 Thousand |
| Stock-based compensation | 54.5 Thousand | 54.5 Thousand | 307 Thousand | 82.5 Thousand | 82.5 Thousand | 71 Thousand |
| Change in working capital | 465 Thousand | 465 Thousand | -297 Thousand | 699.5 Thousand | 699.5 Thousand | -700.99 Thousand |
| Other non-cash items | -334 Thousand | -1.05 Million | 547 Thousand | -117 Thousand | -117 Thousand | 335.49 Thousand |
| Investing Cash Flow | 3.84 Million | 3.84 Million | 2.38 Million | -85.5 Thousand | -85.5 Thousand | 1.27 Million |
| Investments in PPE | -151 Thousand | -151 Thousand | -664 Thousand | -159.5 Thousand | -159.5 Thousand | -172.5 Thousand |
| Acquisitions | - | - | 48 Thousand | 48 Thousand | - | - |
| Investment purchases | - | - | -3.04 Million | - | - | - |
| Sales/Maturities of investments | - | - | 3 Million | - | - | 3 Million |
| Other Investing Activities | 4 Million | 4 Million | 3.04 Million | 74 Thousand | 74 Thousand | 1.45 Million |
| Financing Cash Flow | 2.36 Million | 2.36 Million | -776 Thousand | -306.5 Thousand | -306.5 Thousand | -81.5 Thousand |
| Debt repayment | - | - | -171 Thousand | -171 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.36 Million | 2.36 Million | -605 Thousand | -306.5 Thousand | -306.5 Thousand | -81.5 Thousand |
| Accounts receivables | 465 Thousand | 465 Thousand | 2.56 Million | 950.5 Thousand | 950.5 Thousand | 332 Thousand |
| Accounts payables | - | - | -294 Thousand | -548 Thousand | - | 254 Thousand |
| Inventory | - | - | - | - | - | -1.00 |
| Other working capital | - | - | -2.56 Million | -251 Thousand | -251 Thousand | -1.03 Million |
| Cash at beginning of period | - | - | 22.22 Million | 16.55 Million | - | 22.22 Million |
| Cash at end of period | 2.67 Million | 2.67 Million | 8.67 Million | 8.67 Million | -3.93 Million | 16.55 Million |
| Capital Expenditure | -151 Thousand | -151 Thousand | -664 Thousand | -159.5 Thousand | -159.5 Thousand | -172.5 Thousand |
| Effect of forex changes on cash | 7500.00 | 7500.00 | -39 Thousand | -3500.00 | -3500.00 | -16 Thousand |
| Net cash flow / Change in cash | 2.67 Million | 2.67 Million | -13.55 Million | -7.87 Million | -3.93 Million | -5.67 Million |
| Free Cash Flow | -3.69 Million | -3.69 Million | -15.78 Million | -3.7 Million | -3.7 Million | -4.18 Million |
LOBEF
1708
PGPKY
CHME
NIPOF
CBVTF